How Johnson & Johnson (JNJ) Makes Money: A Visual Guide
Johnson & Johnson (JNJ) generated $94.19B in revenue (TTM through Q4 2025), earning $26.80B in net profit (28.5% margin). Its largest revenue source is Innovative Medicine (64.1% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.
Johnson & Johnson (JNJ) Income Statement Flow
Frequently asked questions
How does Johnson & Johnson (JNJ) make money?
- Johnson & Johnson (JNJ) primarily makes money through Innovative Medicine, which accounts for 64.1% of total revenue. For TTM through Q4 2025, Johnson & Johnson generated $94.19B in total revenue with a net profit margin of 28.5%.
What is Johnson & Johnson (JNJ) gross profit margin?
- Johnson & Johnson (JNJ) reported a gross profit margin of 72.8% for TTM through Q4 2025, equivalent to $68.56B in gross profit. This means Johnson & Johnson retains 72.8% of each revenue unit after direct costs of production.
What is Johnson & Johnson (JNJ) operating profit margin?
- Johnson & Johnson (JNJ) reported an operating profit margin of 27.2% for TTM through Q4 2025, equivalent to $25.60B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Johnson & Johnson (JNJ) net profit margin?
- Johnson & Johnson (JNJ) reported a net profit margin of 28.5% for TTM through Q4 2025, equivalent to $26.80B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Johnson & Johnson (JNJ) invest in R&D?
- Johnson & Johnson (JNJ) invested $14.66B in research and development in TTM through Q4 2025 (15.6% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Johnson & Johnson (JNJ) spend on capital expenditures?
- Johnson & Johnson (JNJ) spent $4.83B on capital expenditures in TTM through Q4 2025 (5.1% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Johnson & Johnson (JNJ) free cash flow?
- Johnson & Johnson (JNJ) generated $19.70B in free cash flow for TTM through Q4 2025 (20.9% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Johnson & Johnson (JNJ) effective tax rate?
- Johnson & Johnson (JNJ) had an effective tax rate of 17.7% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.
About this data
- What is a Sankey diagram?
- A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
- How is the data calculated?
- We use the income statement from company filings. For TTM (Trailing Twelve Months), we sum the last four quarters. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
- When was this data last updated?
- Based on company filings through TTM through Q4 2025.